Ideal outcomes after pancreatoduodenectomy significantly impact survival rates.

A retrospective analysis of 578 pancreatoduodenectomy patients revealed that 42.91% achieved an ‘ideal outcome’ (io). Key factors enhancing io likelihood included neoadjuvant chemotherapy and neuroendocrine tumors. In contrast, older age and percutaneous transhepatic biliary drainage reduced the odds of achieving io. Notably, patients with io demonstrated significantly improved survival rates, underscoring the potential for refined clinical strategies to bolster surgical outcomes by targeting modifiable risk factors.